Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1696046 | 0.85 | ALDH1A1 (0.55) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL14925053 | 0.77 | ERN1 (0.56) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL27823419 | 0.73 | ALDH1A1 (0.65) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL30664869 | 0.72 | KDM4E (0.43) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL17866971 | 0.71 | CYP3A4 (0.53) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL25144434 | 0.71 | HPGD (0.40) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL11095245 | 0.70 | ALDH1A1 (0.69) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL67224 | 0.68 | ALDH1A1 (1.00) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL4274099 | 0.68 | ALDH1A1 (0.88) | ALDH1A1HPGDHSD17B10KDM4ETDP1 | |
| SCHEMBL23901471 | 0.68 | MGAM (0.41) | ALDH1A1HPGDHSD17B10KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210929-A1 | MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-07-06 | — | — | US | claimed |
| US-20220273742-A1 | MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-09-01 | — | — | US | claimed |
| US-20260076897-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Belhaven BioPharma Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4704918-A1 | SYNTHETIC NUCLEIC ACID AND THERAPEUTIC USES THEREOF | Centre National de la Recherche Scientifique (FR) | 2026-03-11 | — | — | EP | disclosed |
| US-20260021042-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Belhaven BioPharma Inc. (US) | 2026-01-22 | — | — | US | disclosed |
| US-20260015627-A1 | COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN TRANSLATION FROM RECOMBINANT CIRCULAR RNAS | UNIV LELAND STANFORD JUNIOR (US) | 2026-01-15 | — | — | US | disclosed |
| US-20260007594-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Belhaven BioPharma Inc. (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4652270-A1 | RNA FORMULATIONS FOR PHARMACEUTICAL USE | BioNTech SE (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-20250345417-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMA | BioNTech SE (DE) | 2025-11-13 | — | — | US | disclosed |
| US-20250333728-A1 | UTR MOLECULE FOR INCREASING PROTEIN EXPRESSION LEVEL | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-10-30 | — | — | US | disclosed |
| EP-4624574-A1 | UTR MOLECULE FOR INCREASING PROTEIN EXPRESSION LEVEL | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-10-01 | — | — | EP | disclosed |
| CN-108738328-B | CRISPR-CAS system for filamentous fungal host cells | 帝斯曼知识产权资产管理有限公司 | 2022-08-02 | — | — | CN | disclosed |
| EP-3491130-B1 | AN ASSEMBLY SYSTEM FOR A EUKARYOTIC CELL | DSM IP ASSETS BV (NL) | 2022-07-27 | — | — | EP | disclosed |
| US-11396665-B2 | CRISPR-CAS system for a filamentous fungal host cell | DSM IP ASSETS B.V. (NL) | 2022-07-26 | — | — | US | disclosed |
| CN-111562319-B | Method for detecting related substances in metformin hydrochloride preparation | 中国人民解放军军事科学院军事医学研究院 | 2022-06-07 | — | — | CN | disclosed |
| US-20220169967-A1 | GREENHOUSE GAS IMPROVED FERMENTATION | DSM IP ASSETS B.V. (NL) | 2022-06-02 | — | — | US | disclosed |
| US-11332751-B2 | Methods and compositions for production of aromatic and other compounds in yeast | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-05-17 | — | — | US | disclosed |
| EP-3987690-A1 | APPARATUS AND METHOD FOR TRANSMITTING AND/OR RECEIVING DATA OVER A FIBER-OPTICAL CHANNEL EMPLOYING PERTURBATION-BASED FIBER NONLINEARITY COMPENSATION IN A PERIODIC FREQUENCY DOMAIN | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-04-27 | — | — | EP | disclosed |
| CN-114269920-A | Methods and compositions for treating cancer | 儿童医疗中心有限公司 | 2022-04-01 | — | — | CN | disclosed |
| US-20220056460-A1 | CRISPR GUIDE-RNA EXPRESSION STRATEGIES FOR MULTIPLEX GENOME ENGINEERING | DSM IP ASSETS B.V. (NL) | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015627-A1 | COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN TRANSLATION FROM RECOMBINANT CIRCULAR RNAS | RNMT, RNGTT, NSUN3 | ALDH1A1 4641/4885HPGD 4702/4885HSD17B10 4357/4885 |
| US-20260007594-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | ADRA1D, ADRB2, ADRB3 | ALDH1A1 3503/4885HPGD 1376/4885HSD17B10 2707/4885 |
| US-20260021042-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | ADRB2, ADRA1D, ADRA2C | ALDH1A1 3676/4885HPGD 1721/4885HSD17B10 3248/4885 |
| US-20260076897-A1 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | COMT, CMA1, ADRB3 | ALDH1A1 670/4885HPGD 320/4885HSD17B10 587/4885 |
| US-20230210929-A1 | MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION | ERG28, MIF, MANBA | ALDH1A1 2118/4885HPGD 1434/4885HSD17B10 2718/4885 |
| US-20250345417-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMA | MSH2, NRAS, TP53 | ALDH1A1 2435/4885HPGD 2250/4885HSD17B10 3599/4885 |
| US-20220273742-A1 | MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION | ERG28, MIF, MANBA | ALDH1A1 2118/4885HPGD 1434/4885HSD17B10 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.